- Home
- GRC vs QURE Comparison
GRC vs QURE Comparison
Compare GRC & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRC
- QURE
- Stock Information
- Founded
- GRC 1933
- QURE 1998
- Country
- GRC United States
- QURE Netherlands
- Employees
- GRC N/A
- QURE N/A
- Industry
- GRC Fluid Controls
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- GRC Industrials
- QURE Health Care
- Exchange
- GRC Nasdaq
- QURE Nasdaq
- Market Cap
- GRC 1.0B
- QURE 860.8M
- IPO Year
- GRC N/A
- QURE 2007
- Fundamental
- Price
- GRC $37.60
- QURE $14.05
- Analyst Decision
- GRC
- QURE Strong Buy
- Analyst Count
- GRC 0
- QURE 8
- Target Price
- GRC N/A
- QURE $32.43
- AVG Volume (30 Days)
- GRC 64.9K
- QURE 1.3M
- Earning Date
- GRC 02-07-2025
- QURE 02-26-2025
- Dividend Yield
- GRC 1.97%
- QURE N/A
- EPS Growth
- GRC 33.88
- QURE N/A
- EPS
- GRC 1.45
- QURE N/A
- Revenue
- GRC $657,528,000.00
- QURE $28,587,000.00
- Revenue This Year
- GRC $1.05
- QURE $153.92
- Revenue Next Year
- GRC $3.60
- QURE N/A
- P/E Ratio
- GRC $25.88
- QURE N/A
- Revenue Growth
- GRC 1.95
- QURE N/A
- 52 Week Low
- GRC $30.47
- QURE $3.73
- 52 Week High
- GRC $43.79
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- GRC 43.39
- QURE 48.03
- Support Level
- GRC $35.48
- QURE $13.04
- Resistance Level
- GRC $37.97
- QURE $14.32
- Average True Range (ATR)
- GRC 0.81
- QURE 1.09
- MACD
- GRC 0.09
- QURE -0.75
- Stochastic Oscillator
- GRC 66.30
- QURE 16.40
About GRC Gorman-Rupp Company (The)
Gorman-Rupp Co designs, manufactures and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of revenue from the United States.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.